Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2024 Consolidated results.
Year Current Liabilities
Mar2024-
Mar2023-
Mar2022-
Mar2013-
Mar2012-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 -
0
Mar2012 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹392.7 Cr 1.5% 9.3% -0.2% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,657.2 Cr -2.5% 0.1% 17.5% Stock Analytics
KAVERI SEED COMPANY ₹6,685.8 Cr -7.2% -2.8% 41% Stock Analytics
VENKYS (INDIA) ₹2,285.5 Cr -1.3% -0.5% -13.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,475.9 Cr -0.8% -2.7% -29.7% Stock Analytics
INDO US BIOTECH ₹302.3 Cr -10.2% -0.5% -28% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

1.5%

9.3%

-0.2%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses